1E. R. Chernykh,V. V. Stupak,G. M. Muradov,M. Yu. Sizikov,E. Ya. Shevela,O. Yu. Leplina,M. A. Tikhonova,A. D. Kulagin,I. A. Lisukov,A. A. Ostanin,V. A. Kozlov. Application of autologous bone marrow stem cells in the therapy of spinal cord injury patients[J] 2007,Bulletin of Experimental Biology and Medicine(4):543～547
2Yamamoto N, Akamatsu H, Hasegawa S. Isolation of muhipotent s- tem cells from mouse adipose tissue[ J]. J Dermatol Sc,2007,48: 43 - 52.
3Im GI, Shin YW,Lee KB. Do adipose tissuederived meseuehymal stem cells have the same osteogenic and chondrogenic potential as bonemarrow-derived cells [ J ]. Osteoarthritis Cartilage, 2005,13 : 845 - 853.
5Koga H,Muneta T, Nagase T, et al. Comparison of mesenchymal tissues-derived stem ceils for in vivo chondrogenesis:suitable condi- tions for cell therapy of cartilage defects in rabbit[ J]. Cell Tissue Res,2008,333(2) :207 -215.
6Le Blanc K, Ringden O. Immunomodulation by mesenchymal stem cells and clinical experience [ J ]. J Intern Med,2007,262 : 509 - 525.
7Uccelli A, Pistoia V, Moretta L. Mesenchymal stem cells: a new strategy for immunosuppression [ J ]. Trends Immunol, 2007,28 (5) :219 -226.
8Chen X,Armstrong MA, Li G. Mesenchymal stem ceils in immuno- regulation [ J ]. Immunol C ell Biol, 2006,84 ( 5 ) : 413 - 421.
